TRAVERSE CITY, Mich., Jan. 22, 2025 /PRNewswire/ — LifeKnight, Inc., a pioneer in AI-enabled safety and health technology, has been named a finalist in the Space, Government & Security category for the 2025 SXSW Pitch. The event, presented by KPMG, showcases the most innovative global startups during the South by Southwest® (SXSW®) Conference & Festivals in Austin, TX, March 7-15, 2025.
Out of 589 applicants, LifeKnight, Inc. is one of 45 finalists across nine categories and will present on March 8, 2025. The company will showcase its AI-enabled LifeKnight Safety and Wellness Platform, which powers the LOIS Safety App, AI agents, and advanced health and safety features. This platform offers groundbreaking capabilities such as real-time emergency detection, automated response, geo-fencing for hazardous areas, and continuous health monitoring.
“Being selected as a finalist is a significant milestone,” said Avery Piantedosi, Founder and CEO of LifeKnight, Inc. “Our platform redefines safety and wellness by leveraging AI to proactively protect lives and transform emergency response.”
LifeKnight, Inc.’s innovations are supported by strategic partnerships with IBM Watson and NVIDIA, emphasizing its leadership in AI-enabled safety technology.
SXSW Pitch will culminate in an awards ceremony on March 9, where category winners and a Best in Show winner will be announced.
For more information, visit: https://www.sxsw.com/pitch
Media Contact:
Lauren Ireland
616.422.0681
389099@email4pr.com
SOURCE LifeKnight, Inc.
The New Year Introduces Continuum's Entry-Level Tier, Starting at $25,000 Per YearNEW YORK, Dec. 22,…
BOSTON, Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with…
CHICAGO, Dec. 22, 2025 /PRNewswire/ -- TrustCommerce®, a Sphere company and leading provider of end-to-end…
MIAMI, Dec. 22, 2025 /PRNewswire/ -- BioFlorida, Inc. ("BioFlorida"), Florida's preeminent life sciences association, is…
Andreessen Horowitz leads the funding round which will accelerate the company's leadingtelehealth marketplaceAUSTIN, Texas, Dec.…
MMJ's position is further fortified by its FDA Orphan Drug Designations for the treatment of…